Analysis of telomerase activity and detection of its catalytic subunit, hTERT

Analytical Biochemistry

Volumn 315, Issue 1, 2003, Pages 1-21

  Saldanha, Sabita N ^a   Andrews, Lucy G ^a   Tollefsbol, Trygve O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Detection techniques; hTERT; Telomerase; TRAP

Indexed keywords

CELL PROLIFERATION; TUMORS;

AMPLIFICATION PROTOCOLS; CELLULAR PROLIFERATIONS; CELLULAR TRANSFORMATION; DISTRIBUTION PATTERNS; HTERT; NEOPLASTIC TRANSFORMATION; TELOMERASE; TRAP;

DIAGNOSIS;

BIOLOGICAL MARKER; TELOMERASE;

AGING; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL TRANSFORMATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FLOW CYTOMETRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR;

EID: 0037381762     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(02)00663-2     Document Type: Review

References (109)

1. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell. Res. 25:1961;585-621.
2. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41:1973;181-190.
3. McClintock B. Fusion of broken ends of chromosomes following nuclear fusion. Proc. Natl. Acad. Sci. USA. 28:1942;458-563.
4. Blackburn E.H. Structure and function of telomeres. Nature. 350:1991;569-573.
5. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., Harley C.B. Telomere length predicts the replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA. 89:1992;10114-10118.
6. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:1985;405-413.
7. Greider C.W., Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 337:1989;331-337.
8. Shippen-Lentz D., Blackburn E.H. Functional evidence for an RNA template in telomerase. Science. 247:1990;546-552.
9. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Linger J., Harley C.B., Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
10. Feng J., Funk W.D., Wang S.-S., Weinrich S.L., Avilion A.A., Chiu C.-P., Adams R.R., Chang E., Allsopp R.C., Yu J., Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., Villeponteau B. The RNA component of human telomerase. Science. 269:1995;1236-1241.
11. Harrington I., McPhail T., Mar V., Zhou W., Oulton R., Bass M.B., Arruda I., Robinson M.O. A mammalian telomerase-associated protein. Science. 275:1997;973-977.
12. Chiu C.-P., Harley C.B. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc. Soc. Exp. Biol. Med. 214:1997;99-106.
13. ′ overhang J. Biol. Chem. 275:2000;19719-19722.
14. Shay J.W. At the end of the millennium, a view of the end. Nat. Genet. 23:1999;382-383.
15. Shore D. Telomeric chromatin: replicating and wrapping up chromosome ends. Curr. Opin. Genet. Dev. 11:2001;189-198.
16. Ancelin K., Brun C., Gilson E. Role of the telomeric DNA-binding protein TRF2 in the stability of human chromosome ends. Bioessays. 20:1998;879-883.
17. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413.
18. de Lange T. Protection of mammalian telomeres. Oncogene. 21:2002;532-540.
19. Goytisolo F.A., Blasco M.A. Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene. 21:2002;584-591.
20. Aragona M., Maisano R., Panetta S., Giudice A., Morelli M., La Torre I., La Torre F. Telomere length maintenance in aging and carcinogenesis. Int. J. Oncol. 17:2000;981-989.
21. Yang L., Suwa T., Wright W.E., Shay J.W., Hornsby P.J. Telomere shortening and decline in replicative potential as a function of donor age in human adrenocortical cells. Mech. Ageing Dev. 122:2001;1685-1694.
22. Cerni C. Telomeres, telomerase, and myc. An update. Mutat. Res. 462:2000;31-47.
23. Urquidi V., Tarin D., Goodison S. Role of telomerase in cell senescence and oncogenesis. Annu. Rev. Med. 51:2000;65-79.
24. Li H., Cao Y., Berndt M.C., Funder J.W., Liu J.P. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene. 18:1999;6785-6794.
25. Latil A., Viduad D., Valeri A., Fournier G., Viduad M., Lidereau R., Cussenot O., Bieche I. hTERT expression correlates with MYC over-expression in human prostate cancer. Int. J. Cancer. 89:2000;172-176.
26. Oh S., Song Y.H., Kim U.J., Yim J., Kim T.K. In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells. Biochem. Biophys. Res. Commun. 263:1999;361-365.
27. Poremba C., Scheel C., Hero B., Christiansen H., Schaefer K-L., Nakayama J-i., Berthold F., Juergens H., Boecker W., Dockhorn-Dwornniczak B. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues. Clin. Oncol. 18:2000;2582-2592.
28. Jong H.-S., Park Y.I., Kim S., Sohn J.H., Kang S.H., Song S.H., Bang Y.-J., Kim N.K. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer. 86:1999;559-565.
29. Pendino F., Flexor M., Delhommeau F., Buet D., Lanotte M., Segal-Bendirdjian E. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc. Natl. Acad. Sci. USA. 98:2001;6662-6667.
30. Poole J.C., Andrews L.G., Tollefsbol T.O. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene. 269:2001;1-12.
31. Wu Y.-Y., Hruszkewye A.M., Delgado R.M., Yang A., Vortmeyer O.A., Moon Y.-W., Weil R.J., Zhuang Z., Remaley A.T. Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. Clin. Chem. Acta. 293:2000;199-212.
32. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.M., Wright W.E., Weinrich S,L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
33. Bechter O.E., Eisterer W., Pall G., Hilbe W., Kuhr T., Thaler J. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res. 58:1998;4918-4922.
34. Bryan T.M., Englezou A., Dunham M.A., Reddel R.R. Telomere length dynamics in telomerase-positive immortal human cell populations. Exp. Cell. Res. 239:1998;370-378.
35. Kageyama Y., Kamata S., Yonese J., Oshima H. Telomere length and telomerase activity in bladder and prostate cancer cell lines. Int. J. Urol. 4:1997;407-410.
36. Leber B., Bacchetti S. Telomeres and telomerase in normal and malignant haematologic cells. Leuk. Lymphoma. 24:1996;1-9.
37. Maruyama Y., Hanai H., Fujita M., Kaneko E. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn. J. Clin. Oncol. 27:1997;216-220.
38. Murakami J., Nagai N., Ohama K. Telomerase activity and telomere length as diagnostic tumor marker for ovarian tumors. Nippon Rinsho. 56:1998;1310-1315.
39. Nakashio R., Kitamoto M., Nakanishi T., Takaishi H., Takahashi S., Kajiyama G. Telomere length and telomerase activity in hepatocellular carcinoma. Nippon Rinsho. 56:1998;1239-1243.
40. Schroder C.P., Wisman G.B., de Jong S., van der Graaf W.T., Ruiters M.H., Mulder N.H., de Leij L.F., van der Zee A.G., de Vries E.G. Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br. J. Cancer. 84:2001;1348-1353.
41. Wright W.E., Tesmer V.M., Huffman K.E., Levene S.D., Shay J.W. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 11:1997;2801-2809.
42. ′ -overhang measured by oligonucleotide ligation assay Nucleic Acids Res. 29:2001;1-6.
43. Arinaga M., Shimizu S., Gotoh K., Haruki N., Takahashi T., Mitsudomi T. Expression of human telomerase subunit genes in primary lung cancer and its clinical significance. Ann. Thorac. Surg. 70:2000;401-405. discussion 405-406.
44. De Kok J.B., Schalken J.A., Aalders T.W., Ruers T.J., Willems H.L., Swinkels D.W. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas. Int. J. Cancer. 87:2000;217-220.
45. de Kok J.B., Ruers T.J., van Muijen G.N., van Bokhoven A., Willems H.L., Swinkels D.W. Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin. Chem. 46:2000;313-318.
46. Hiyama E., Hiyama K., Yokoyama T., Shay J.W. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia. 3:2001;17-26.
47. Itoi T., Shinohara Y., Takeda K., Nakamura K., Shimizu M., Ohyashiki K., Hisatomi H., Nakano H., Moriyasu F. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers. Int. J. Mol. Med. 7:2001;281-287.
48. Lee B.K., Diebel E., Neukam F.W., Wiltfang J., Ries J. Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer. Int. J. Oncol. 19:2001;1063-1068.
49. Schneider-Stock R., Emrich T., Peters B., Jaeger V., Roessner A. Analysis of human telomerase reverse transcriptase mRNA (hTERT) expression in myxoid liposarcomas using LightCycler real-time quantitative reverse transcriptase-polymerase chain reaction. Electrophoresis. 22:2001;1098-1101.
50. Schrader M., Muller M., Heicappell R., Straub B., Miller K. Quantification of human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) mRNA in testicular tissue of infertile patients. Asian J. Androl. 3:2001;263-270.
51. Schrader M., Muller M., Schulze W., Heicappell R., Krause H., Straub B., Miller K. Quantification of the expression level of the gene encoding the catalytic subunit of telomerase in testicular tissue specimens predicts successful sperm recovery. Hum. Reprod. 17:2002;150-156.
52. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
53. Morin G.B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 59:1989;521-529.
54. Counter C.M., Botelho F.M., Wang P., Harley C.B., Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol. 68:1994;3410-3414.
55. Holt S.E., Norton J.C., Wright W.E., Shay J.W. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell. Sci. 18:1996;237-248.
56. Krupp G., Kuhne K., Tamm S., Klapper W., Heidron K., Rott A., Parwaresch R. Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay. Nucleic Acids Res. 25:1997;919-921.
57. Falchetti M.L., Levi A., Molinari P., Verma R., D'Ambrosio Increase sensitivity and reproducibility of TRAP assay by avoiding primers interaction. Nucleic Acids Res. 26:1998;862-863.
58. Kim N.W., Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25:1997;2595-2597.
59. Uehara H., Nardone G., nazarenko I., Hohman R.J. Detection of telomerase activity utilizing energy transfer primers: comparison with gel-and ELISA-based detection. BioTechniques. 26:1999;552-558.
60. Piatyszek M.A., Kim N.W., Weinrich S.L., Hiyama K., Hiyama E., Wright W.E., Shay J.W. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell. Sci. 17:1995;1-15.
61. Wright W.E., Shay J.W., Piatyszek M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23:1995;3794-3795.
62. Gollahon L.S., Holt S.E. Alternative methods of extracting telomerase activity from human tumor samples. Cancer Lett. 159:2000;141-149.
63. Szatmari I., Tokes S., Dunn C.B., Bardos T.J., Aradi J. Modified telomeric repeat amplification protocol: a quantitative radioactive assay for telomerase without using electrophoresis. Anal. Biochem. 282:2000;80-88.
64. Szatmari I., Aradi J. Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme. Nucleic Acids Res. 29:2001;1-4.
65. Bosworth N., Towers P. Scintillation proximity assay. Nature. 341:1989;167-168.
66. Savoysky E., Akamatsu K-i., Tsuchiya M., Yamazaki T. Detection of telomerase activity by combination of TRAP method and scintillation proximity assay (SPA). Nucleic Acids Res. 24:1996;1175-1176.
67. Hou M., Xu D., Bjorkholm M., Gruber A. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin. Chem. 47:2001;519-524.
68. Wang Z., Ramin S.A., Tsai C., Lui P., Ruckle H.C., Beltz R.E., Sands J.F. Telomerase activity in prostate sextant needle cores from radiation prostatectomy specimens. Urol. Oncol. 6:2001;57-62.
69. Wang Z., Ramin S.A., Tsai C., Lui P., Herbert P.J., Kyeyune-Nyombi E., Ruckle H.C., Beltz R.E., Sands J.F. Detection of telomerase activity in prostatic fluid specimens. Urol. Oncol. 6:2000;4-9.
70. Braunschweig R., Yan P., Guilleret I., Delacretaz F., Bosman F.T., Mihaescu A., Benhattar J. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn. Cytopathol. 24:2001;174-180.
71. Tatsuma T., Goto S., Kitano S., Lin Y.C., Lee C.M., Chen C.L. Telomerase activity in peripheral blood for diagnosis of hepatoma. Gastroenterol. Hepatol. 15:2000;1064-1070.
72. Poremba C., Shroyer K.R., Frost M., Diallo R., Fogt F., Schafer K.L., Burger H., Shroyer A.L., Dockhorn-Dworniczak B., Boecker W. Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions. J. Clin. Oncol. 17:1999;2020-2026.
73. Cheng C.W., Chueh S.C., Chern H.D. Diagnosis of bladder cancer using telomerase activity in voided urine. J. Formos. Med. Assoc. 99:2000;920-925.
74. Pearson A.S., Gollahon L.S., O'Neal N.C., Saboorian H., Shay J.W., Fahey T.J. III Detection of telomerase activity in breast masses by fine-needle aspiration. Ann. Surg. Oncol. 5:1998;186-193.
75. Gauthier L.R., Granotier C., Soria J.C., Faivre S., Boige V., Raymond E. Detection of circulating carcinoma cells by telomerase activity. Br. J. Cancer. 84:2001;631-635.
76. Arnold l.J., Hammond P.W., Wiese W.A., Nelson N.C. Assay formats involving acridium-ester labeled DNA probes. Clin. Chem. 35:1989;1588-1594.
77. Dhingra K., Talpaz M., Riggs M., Eastman P.S., Zipf T., Ku S., Kurzrock R. Hybridization protection assay: a rapid, sensitive, and specific method for detection of philadelphia chromosome-positive leukemias. Blood. 77:1991;238-242.
78. Hirose M., Hashimoto J.A., Tahara H., Ide T., Yoshimura T. New method to measure telomerase activity by transcription-mediated amplification and hybridizatrion protection assay. Clin. Chem. 44:1998;2446-2452.
79. Verhaegen M., Christopoulos T.K. Quantitative polymerase chain reaction based on a dual-analyte chemiluminescence hybridization assay for target DNA and internal standard. Anal. Chem. 70:1998;4120-4125.
80. Kolioliou M., Talieri M., Lianidou E.S. Development of a quantitative luminometric hybridization assay for the determination of telomerase activity. Clin. Biochem. 34:2001;277-284.
81. Lackely D.B. A homogenous chemiluminescent assay for telomerase. Anal. Biochem. 263:1998;57-61.
82. Hiyama E., Saeki T., Hiyama K., Takashima S., Shay J.W., Matsuura Y., Yokoyama T. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples. Cancer. 90:2000;235-238.
83. Yashima K., Milchgrub S., Gollahon L.S., Maitra A., Saboorian M.H., Shay J.W., Gazdar A.F. Telomerase enzyme activity and RNA expression during multistage pathogenesis of breast carcinoma. Clin. Cancer Res. 4:1998;229-234.
84. Norton J.C., Holt S.E., Wright W.E., Shay J.W. Enhanced detection of human telomerase activity. DNA Cell. Biol. 17:1998;217-219.
85. Fletcher T.M., Trevino A., Woynarowski J.M. Enzymatic activity of endogenous telomerase associated with intact nuclei from human leukemia CEM cells. Biochem. Biophys. Res. Commun. 265:1999;51-56.
86. ′ -triphosphate Bioorg. Chem. 29:2001;36-55.
87. Yan P., Bosman F.T., Benhattar Tissue quality is an important determinant of telomerase activity as measured by TRAP. BioTechniques. 25:1998;660-662.
88. Tesmer V.M., Ford L.P., Holt S.E., Frank B.C., Yi X., Aisner D.L., Quellette M., Shay J.W., Wright W.E. Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol. Cell. Biol. 19:1999;6207-6216.
89. Falchetti M.L., Pallini R., D'Ambrosio E., Pierconti F., Martini M., Cimino-Reale G., Verna R., Maira G., Larocca L.M. In situ detection of telomerase catalytic subunit mRNA in Glioblastoma multiforme. Int. J. Cancer. 88:2000;895-901.
90. Ali A.S.M., Chopra R., Robertson J., Testa N.G. Detection of hTERT protein by flow cytometry. Leukemia. 14:2000;2176-2181.
91. Harada K., Yasoshima M., Ozaki S., Sanzen T., Nakanuma Y. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers. J. Pathol. 193:2001;210-217.
92. Fujimoto R., Kamata N., Yokoyama K., Ueda N., Satomura K., Hayashi E., Nagayama M. Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral. Oncol. 37:2001;132-140.
93. Kolquist K.A., Ellisen L.W., Counter C.M., Meyerson M., Tan L.K., Weinberg R.A., Haber D.A., Gerald W.L. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nature. 19:1998;182-186.
94. Liu K., Schoonmaker M.M., Levine B.L., June C.H., Hodes R.J., Wueng N.P. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. USA. 96:1999;5147-5152.
95. Nakano K., Watney E., McDougall J.K. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am. J. Pathol. 153:1998;857-864.
96. Maitra A., Rathi A., Gazdar A.F., Sagalowsky A., Ashfaq R. Expression of the RNA component of human telomerase (hTR) in thin prep preparations from bladder washings. Cancer. 93:2001;73-79.
97. Maggiano N., Piantelli M., Ricci R., Larocca L.M., Capelli A., Ranelletti F.O. Detection of growth hormone-producing cells in human thymus by immunohistocytochemistry and non-radiactive in situ hybridization. J. Histochem. Cytochem. 42:1994;1349-1354.
98. Dome J.S., Chung S., Bergemann T., Umbritch C.B., Saji M., Carey L.A., Grundy P.E., Periman E.J., Breslow N.E., Sukumar S. High telomerase reverse transcriptase (hTERT) messenger RNA levels correlates with tumor recurrence in patients with favorable histology Wilms' tumor. Cancer Res. 59:1999;4301-4307.
99. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genom. Res. 6:1996;986-994.
100. Bieche I., Nogues C., Paradis V., Olivi M., Bedossa P., Lidereau, Viduad M. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin. Cancer Res. 6:2000;452-459.
101. Emrich T., Karl G., Panzinger B. Detection of telomerase components by quantitative real-time-on-line PCR analysis with the LightCycler. Biochemica. 4:2000;16-19.
102. Emrich T., Karl G., Panzinger B. The LightCycler instrument and MagNA pure LC: an automated system for the evaluation of telomerase expression by quantitative RT-PCR. Biochemica. 4:2000;10-13.
103. Sato N., Maehara N., Mizumoto K., Nagai E., Yasoshima T., Hirata K., Tanaka M. Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion. Cancer. 91:2001;496-504.
104. Chen X.Q., Bonnefoi H., Pelte M.F., Lyautey J., Lederrey C., Movarekhi S., Schaeffer P., Mulcahy H.E., Meyer P., Stroun M., Anker P. Telomerase RNA detection marker in the serum of breast cancer patients. Clin. Cancer Res. 6:2000;3823-3826.
105. Kobayashi T., Kubota K., Takayama T., Makuuchi M. Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy. Am. J. Surg. 181:2001;284-288.
106. Gross R., Schiffer D. Prognostic significance of telomerase in brain tumors. Crit. Rev. Neurosurg. 8:1998;244-247.
107. Ulaner G.A., Hu J.F., Vu T.H., Giudice L.C., Hoffman A.R. Tissue- specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int. J. Cancer. 91:2001;644-649.
108. Yi X., White D.M., Aisner D.L., Baur J.A., Wright W.E., Shay J.W. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia. 2:2000;433-440.
109. Ulaner G.A., Hu J.F., Vu T.H., Giudice L.C., Hoffman A.R. Telomerase activity in human development is regulated by human telomerase reverse transcritpase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:1998;4168-4172.